- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT00498706
Effectiveness of Telephone Versus Face-to-Face CBT in Treating People With Depression
Telephone Versus Face-to-Face Administration of CBT for Depression
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
Major depressive disorder is a common and often long-lasting disorder with 12-month prevalence rates estimated to be between 6.6% and 10.3%. Although the personal and societal costs of depression are high, it is well established that depression can be effectively treated using antidepressant medication and/or forms of psychotherapy. Several studies have found that when given a choice, about two-thirds of depressed patients prefer psychotherapy or counseling over antidepressant medication. However, a variety of barriers exist to initiating and maintaining psychotherapy. Only about 20% of all patients referred for psychotherapy actually initiate treatment, and of those who do initiate treatment, nearly half drop out before completing treatment. The use of the telephone to deliver treatment services has been recommended as a way to reduce many of the barriers associated with failure to initiate and sustain treatment. When administered over the telephone, cognitive behavioral therapy (CBT), a form of psychotherapy that teaches ways to modify thoughts and behaviors that contribute to depression, may be superior to face-to-face CBT in improving treatment adherence and reducing depressive symptoms. This study will compare the effectiveness of telephone CBT (T-CBT) versus face-to-face CBT (FtF-CBT) in treating people with depression.
Participation in this study will include 18 weeks of treatment and 12 months of follow-up. All participants will first undergo baseline assessments that will include a telephone interview and questionnaires about mood. Participants will then be assigned randomly to receive T-CBT or FtF-CBT. Participants in both groups will receive eighteen 45-minute sessions of their assigned treatment over 18 weeks. Sessions will occur twice a week for 2 weeks, once a week for 12 weeks, and once every 2 weeks for the last 4 weeks. During sessions, participants will learn ways to modify thoughts and behaviors that contribute to their depression and ways to maintain the lifestyle changes that they have made. Treatment sessions will be identical for both groups, except one group will receive sessions over the telephone and the other in-person at a study office. All participants will repeat the baseline assessments at Weeks 4, 9, 14, and 18 of treatment and Months 3, 6, 9, and 12 of follow-up.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Phase 3
Kontakte und Standorte
Studienorte
-
-
Illinois
-
Chicago, Illinois, Vereinigte Staaten, 60611
- Northwestern University
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Has a current diagnosis of major depressive disorder
- Has a primary care physician at Northwestern University in Illinois, or one of a number of approved community clinics in Chicago.
- Resides in Illinois
- Has a telephone
- Speaks and reads English
Exclusion Criteria:
- Hearing, voice, or visual impairment
- Meets criteria for dementia
- Diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, current substance abuse, or other condition for which participation in a clinical trial of psychotherapy may be either inappropriate or dangerous
- Currently receiving individual psychotherapy or planning to receive psychotherapy during the treatment phase of the study
- Planning to be out of town or unavailable for treatment for 4 weeks or more during the scheduled treatment time
- Recent history of suicide attempts or is severely suicidal
- Initiated treatment with an antidepressant in the 2 months before study entry (antidepressant medication is not exclusionary)
- Depression determined to be primarily of an organic etiology
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Telephone-administered CBT
Participants will receive telephone-administered cognitive behavioral therapy.
|
Over 18 weeks, participants will receive eighteen 45-minute sessions of T-CBT administered by a therapist.
Participants will undergo telephone-administered sessions twice a week for 2 weeks, once a week for 12 weeks, and once every 2 weeks for the last 4 weeks.
Participants will be taught ways to modify thoughts and behaviors that contribute to their depression and ways to maintain the lifestyle changes that they have made.
|
Aktiver Komparator: Face-to-face CBT
Participants will receive face-to-face cognitive behavioral therapy.
|
Over 18 weeks, participants will receive eighteen 45-minute sessions of FtF-CBT administered by a therapist.
Participants will undergo face-to-face administered sessions twice a week for 2 weeks, once a week for 12 weeks, and once every 2 weeks for the last 4 weeks.
Participants will be taught ways to modify thoughts and behaviors that contribute to their depression and ways to maintain the lifestyle changes that they have made.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Attrition (Number of Therapy Sessions Attended)
Zeitfenster: Post treatment, up to 18 weeks
|
Number of therapy sessions attended was collected.
At the end of treatment, the total number of sessions attended by each patient was collected.
|
Post treatment, up to 18 weeks
|
Number of Participants Who Dropped Out of Therapy
Zeitfenster: Post treatment, up to 18 weeks
|
Using the number of therapy sessions attended, we categorized patients into:
|
Post treatment, up to 18 weeks
|
Patient Health Questionnaire (PHQ)-9
Zeitfenster: Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6 post-treatment follow-up
|
Measures depression on a 9 - item scale.
Scores range from 0-27, with 0 being no symptoms.
A difference of 5 or more points on the PHQ-9 is considered a clinically meaningful response to treatment.
|
Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6 post-treatment follow-up
|
Depression, as Assessed by Hamilton Depression Rating Scale(Ham-D)
Zeitfenster: Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6, 9, and 12 of follow-up
|
Ham-D indicates Hamilton Depression Rating Scale,range is 0 to 52.
A score of 0 means the best outcome with no depression symptoms reported, and a score of 52 is the worse outcome with highest level of depression reported.
A difference of 3 points on the Hamilton scale has been identified as clinically significant.
|
Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6, 9, and 12 of follow-up
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
Health-related Quality of Life (SF-36V), Patient Satisfaction (Satisfaction Index - Mental Health), and Therapeutic Alliance (Working Alliance Inventory - Short Form)
Zeitfenster: Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6, 9, and 12 of follow-up
|
Measured at baseline; Weeks 4, 9, 14, and 18; and Months 3, 6, 9, and 12 of follow-up
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: David C. Mohr, PhD, Northwestern University
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- R01MH059708 (US NIH Stipendium/Vertrag)
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Depression
-
Washington University School of MedicineAbgeschlossenBehandlungsresistente Depression | Altersdepression | Altersdepression | Refraktäre Depression | Therapieresistente DepressionVereinigte Staaten, Kanada
-
Brigham and Women's HospitalRekrutierungDepression | Bipolare Störung | Bipolare Depression | Episode einer Major Depression | Bipolare I-Depression | Bipolare II-DepressionVereinigte Staaten
-
Ludwig-Maximilians - University of MunichAbgeschlossenTherapieresistente Major DepressionDeutschland
-
Stony Brook UniversityRekrutierungDepression; DepressionVereinigte Staaten
-
St Patrick's Hospital, IrelandAbgeschlossenBipolare Depression | Unipolare Depression | Episode einer Major DepressionIrland
-
University of Dublin, Trinity CollegeRekrutierungBipolare Depression | Unipolare Depression | Episode einer Major DepressionIrland
-
Baylor College of MedicineIcahn School of Medicine at Mount SinaiAbgeschlossenMajor Depression (MDD) | Behandlungsresistente Depression (TRD)Vereinigte Staaten
-
University Health Network, TorontoAbgeschlossenBipolare Störung | Bipolare Depression | Bipolare I-Depression | Bipolare II-DepressionKanada
-
Paul J. LamotheUnbekanntBehandlungsresistente Depression | Depression,Mexiko
-
Soterix MedicalNYU Langone HealthAbgeschlossenBehandlungsresistente Depression | Unipolare DepressionVereinigte Staaten
Klinische Studien zur Telephone-administered cognitive behavioral therapy (T-CBT)
-
University of Social Sciences and Humanities, WarsawLondon School of Hygiene and Tropical Medicine; Institut National de la Santé... und andere MitarbeiterAbgeschlossen
-
Florida State UniversityAbgeschlossenAdhärenz, Behandlung | Zurückbehaltung | Kognitive Beeinträchtigung, leichtVereinigte Staaten
-
Linnaeus UniversityKarolinska Institutet; Capio Group; The Kamprad Family Foundation for Entrepreneurship...RekrutierungDepression | Zwangsstörung | Ausbrennen | Stress, Psychisch | Schlaflosigkeit | Generalisierte Angststörung | Psychische Belastung | Soziale Angststörung | Panikstörung | Anpassungsstörungen | Hypochondrie | Lebensstilbedingte Krankheit | LebensstressSchweden